The Conversation (0)
The Times of India reports that a new drug has shown promising results with for treating patients with melanoma, the deadliest form of skin cancer.
The Times of India reports that a new drug has shown promising results with for treating patients with melanoma, the deadliest form of skin cancer.
As quoted in the market news:
The results are from the first clinical trial of the drug lambrolizumab (MK3475), which was discovered and developed by Merck (NYSE:MRK). Researchers analyzed 135 patients with advanced metastatic melanoma who were divided into three groups with different treatment regimens.
Click here for the full Times of India article